Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
ARRAYED MOLECULAR BARCODING IDENTIFIES TNFSF13 AS A POSITIVE REGULATOR OF ACUTE MYELOID LEUKEMIA-INITIATING CELLS
27 ledna, 2021 8:37 pmAuthor(s): Marion Chapellier, Pablo Peña-Martínez, Ramprasad Ramakrishnan, Mia Eriksson, et al. Abstract: S815 Session topic: 3. Acute myeloid...
RESULTS OF PIVOTAL PHASE 2 TRIAL OF SL-401 IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
27 ledna, 2021 8:37 pmAuthor(s): Naveen Pemmaraju, Kendra Sweet, Andrew Lane, Anthony Stein, et al. Abstract: S116 Session topic: 4. Acute myeloid...
AKUTNÍ MYELOIDNÍ LEUKEMIE – NOVINKY V DIAGNOSTICE A LÉČBĚ
27 ledna, 2021 8:37 pmKonference EHA 2018, konaná ve Stockholmu, se věnovala extenzivně oblasti preleukemických predispozičních stavů a dále vlivu stárnutí na patogenezi akutní myeloidní leukemie (AML)....
LONG-TERM SAFETY AND EFFICACY OF RITUXIMAB IN 248 ADULT IMMUNE THROMBOCYTOPENIA PATIENTS: RESULTS WITH MORE THAN 5 YEARS OF FOLLOW-UP FROM A FRENCH PROSPECTIVE REGISTRY ITP-RITUX
27 ledna, 2021 8:37 pmAuthor(s): Samuel Deshayes, Mehdi Khellaf, Anissa Zarour, et. al. Abstract: S141 Session topic: 33. Platelets disorders Background...
COMPARISON OF STANDARD- AND LOW-DOSE RITUXIMAB IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP): DATA FROM THE UK ITP REGISTRY
27 ledna, 2021 8:37 pmAuthor(s): Caitlin Gracie, Abbas Zaidi, Umesh Doobaree, et. al. Abstract: S139 Session topic: 33. Platelets disorders Background...
FACTORS AFFECTING THROMBOPOIETIN RECEPTOR AGONIST REINITIATION AFTER DISCONTINUATION IN WELL-CONTROLLED PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN THE UK: RESULTS FROM A MODIFIED DELPHI CONSENSUS PANEL
27 ledna, 2021 8:37 pmAuthor(s): Nichola Cooper, Quentin Hill, John Grainger, et. al. Abstract: PS1411 Session topic: 33. Platelets disorders Background...
ELTROMBOPAG TREATMENT IN PATIENTS WITH PERSISTENT VERSUS CHRONIC IMMUNE THROMBOCYTOPENIA: COMPARISON OF EFFICACY AND SAFETY RESULTS FROM THE PHASE III EXTEND STUDY AND A PHASE IV STUDY
27 ledna, 2021 8:37 pmAuthor(s): Raymond SM Wong, Oliver Meyer, Tahir Shamsi, et. al. Abstract: PF671 Session topic: 33. Platelets disorders ...
FINAL SAFETY AND EFFICACY DATA OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
27 ledna, 2021 8:37 pmAuthor(s): Michael Tarantino, James Bussel, Victor Blanchette, et. al. Abstract: PF655 Session topic: 33. Platelets disorders Background...
PERIOPERATIVE USE OF ELTROMBOPAG IN PATIENTS WITH CHRONIC THROMBOCYTOPENIA. A SINGLE-CENTER EXPERIENCE
27 ledna, 2021 8:37 pmAuthor(s): Elena Landete, Amalia Domingo, Gloria Pérez-Rus, et. al. Abstract: PB2350 Session topic: 33. Platelets disorders Background...
Aktuálne otázky liečby primárnej imunitnej trombocytopénie
27 ledna, 2021 8:37 pmNa tohoročnom 23. Kongrese EHA sa prezentácie o imunitnej trombocytopénii dotýkali štyroch základných okruhov liečby ITP: 1) liečba TPO-RA, bezpečnosť prolongovanej liečby...